Advertisement
ENOV vs SIBN
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ENOV is a Hold and SIBN is a Hold.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
ENOV’s FA Score shows that 0 FA rating(s) are green whileSIBN’s FA Score has 0 green FA rating(s).
- ENOV’s FA Score: 0 green, 5 red.
- SIBN’s FA Score: 0 green, 5 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
ENOV’s TA Score shows that 5 TA indicator(s) are bullish while SIBN’s TA Score has 5 bullish TA indicator(s).
- ENOV’s TA Score: 5 bullish, 5 bearish.
- SIBN’s TA Score: 5 bullish, 4 bearish.
Price Growth
ENOV (@Medical/Nursing Services) experienced а 0.00% price change this week, while SIBN (@Medical/Nursing Services) price change was +5.44% for the same time period.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -0.94%. For the same industry, the average monthly price growth was +6.51%, and the average quarterly price growth was -7.37%.
Reported Earning Dates
ENOV is expected to report earnings on Nov 11, 2026.
SIBN is expected to report earnings on Nov 09, 2026.
Industries' Descriptions
@Medical/Nursing Services (-0.94% weekly)The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
| ENOV | SIBN | ENOV / SIBN | |
| Capitalization | 1.5B | 895M | 168% |
| EBITDA | -770.33M | -8.03M | 9,594% |
| Gain YTD | -2.177 | 1.217 | -179% |
| P/E Ratio | N/A | N/A | - |
| Revenue | 2.28B | 206M | 1,106% |
| Total Cash | 33.1M | 145M | 23% |
| Total Debt | 1.41B | 42.9M | 3,289% |
ENOV | SIBN | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 9 | 50 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 83 Overvalued | 34 Fair valued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 99 | 94 | |
PRICE GROWTH RATING 1..100 | 52 | 39 | |
P/E GROWTH RATING 1..100 | 98 | 100 | |
SEASONALITY SCORE 1..100 | 50 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
SIBN's Valuation (34) in the Medical Specialties industry is somewhat better than the same rating for ENOV (83) in the Industrial Machinery industry. This means that SIBN’s stock grew somewhat faster than ENOV’s over the last 12 months.
SIBN's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as ENOV (100) in the Industrial Machinery industry. This means that SIBN’s stock grew similarly to ENOV’s over the last 12 months.
SIBN's SMR Rating (94) in the Medical Specialties industry is in the same range as ENOV (99) in the Industrial Machinery industry. This means that SIBN’s stock grew similarly to ENOV’s over the last 12 months.
SIBN's Price Growth Rating (39) in the Medical Specialties industry is in the same range as ENOV (52) in the Industrial Machinery industry. This means that SIBN’s stock grew similarly to ENOV’s over the last 12 months.
ENOV's P/E Growth Rating (98) in the Industrial Machinery industry is in the same range as SIBN (100) in the Medical Specialties industry. This means that ENOV’s stock grew similarly to SIBN’s over the last 12 months.
| ENOV | SIBN | |
|---|---|---|
| RSI ODDS (%) | 3 days ago 73% | 3 days ago 71% |
| Stochastic ODDS (%) | 3 days ago 67% | 3 days ago 74% |
| Momentum ODDS (%) | 3 days ago 85% | 3 days ago 76% |
| MACD ODDS (%) | 3 days ago 75% | 3 days ago 76% |
| TrendWeek ODDS (%) | 3 days ago 66% | 3 days ago 76% |
| TrendMonth ODDS (%) | 3 days ago 77% | 3 days ago 79% |
| Advances ODDS (%) | 10 days ago 62% | 5 days ago 76% |
| Declines ODDS (%) | 3 days ago 78% | 10 days ago 78% |
| BollingerBands ODDS (%) | 3 days ago 73% | 3 days ago 82% |
| Aroon ODDS (%) | 3 days ago 51% | 3 days ago 72% |
Advertisement
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| VIEIX | 186.28 | 1.58 | +0.86% |
| Vanguard Extended Market Index Instl | |||
| DLQAX | 12.66 | 0.06 | +0.48% |
| BNY Mellon Large Cap Equity A | |||
| RYSEX | 18.15 | 0.07 | +0.39% |
| Royce Small-Cap Special Equity Invmt | |||
| CFILX | 16.30 | 0.05 | +0.31% |
| Columbia Flexible Capital Income S | |||
| FRIRX | 12.44 | N/A | N/A |
| Fidelity Advisor Real Estate Income I | |||
ENOV and
Correlation & Price change
A.I.dvisor indicates that over the last year, ENOV has been loosely correlated with FELE. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if ENOV jumps, then FELE could also see price increases.
| Ticker / NAME | Correlation To ENOV | 1D Price Change % | ||
|---|---|---|---|---|
| ENOV | 100% | -0.46% | ||
| FELE - ENOV | 56% Loosely correlated | +0.81% | ||
| DOV - ENOV | 55% Loosely correlated | +1.02% | ||
| CNMD - ENOV | 54% Loosely correlated | -0.60% | ||
| PH - ENOV | 53% Loosely correlated | +0.16% | ||
| SNN - ENOV | 52% Loosely correlated | +0.76% | ||
More | ||||
SIBN and
Correlation & Price change
A.I.dvisor indicates that over the last year, SIBN has been loosely correlated with ATEC. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if SIBN jumps, then ATEC could also see price increases.
| Ticker / NAME | Correlation To SIBN | 1D Price Change % | ||
|---|---|---|---|---|
| SIBN | 100% | +2.46% | ||
| ATEC - SIBN | 53% Loosely correlated | +2.05% | ||
| OFIX - SIBN | 44% Loosely correlated | N/A | ||
| SYK - SIBN | 43% Loosely correlated | +0.53% | ||
| ENOV - SIBN | 43% Loosely correlated | -0.46% | ||
| STE - SIBN | 43% Loosely correlated | +0.93% | ||
More | ||||